Association of Lung Cancer and Tea-Drinking Habits of Different Subgroup Populations: Meta-Analysis of Case-Control Studies and Cohort Studies
- PMID: 31700812
- PMCID: PMC6825660
Association of Lung Cancer and Tea-Drinking Habits of Different Subgroup Populations: Meta-Analysis of Case-Control Studies and Cohort Studies
Abstract
Background: We aimed to investigate the association between lung cancer and tea-drinking habits of different subgroup populations.
Methods: Systematic search of the PubMed, Web of Science, China National Knowledge Infrastructure (CNKI) and Sinomed databases from database construction until January 2017 for English and Chinese language articles on association of lung cancer and tea drinking. Meta-analysis was used to calculate the combined odds ratio (OR) value and its 95% confidence interval (95% CI). The Newcastle-Ottawa scale was used to evaluate the quality of the studies and Q-test and I2 was used for heterogeneity testing.
Results: Forty two papers were included, 30 case-control studies included 14578 lung cancer patients and 180574 controls, 12 cohort studies included 543825 subjects, of which the outcome was 5085 with lung cancer. Tea drinkers were found to have a decreased OR of lung cancer compared with non-tea drinkers (OR 0. 80, 95% CI: 0. 73, 0. 87). Consumption of green, black or unspecified tea has a protective effect compared with not drinking tea at all. Increased intake of green tea to 7. 5 g per day can further reduce the OR of lung cancer (OR 0. 69, 95% CI: 0. 48-0. 98). Tea consumption had a protective effect against lung cancer in non-smokers, Further analysis found that drinking of one or more cups of tea a day has a protective effect on smokers (OR 0. 79, 95% CI: 0. 64-0. 96).
Conclusion: Tea drinking could be a protective factor in lung cancer.
Keywords: Case-control studies; Cohort studies; Lung cancer; Meta-analysis; Tea.
Copyright© Iranian Public Health Association & Tehran University of Medical Sciences.
Conflict of interest statement
Conflict of interests The authors declare that there is no conflict of interests.
Figures
Similar articles
-
Tea consumption and lung cancer risk: a meta-analysis of case-control and cohort studies.Nutrition. 2014 Oct;30(10):1122-7. doi: 10.1016/j.nut.2014.02.023. Epub 2014 Mar 12. Nutrition. 2014. PMID: 25194612
-
Green tea consumption and risk of esophageal cancer: a meta-analysis of epidemiologic studies.BMC Gastroenterol. 2012 Nov 21;12:165. doi: 10.1186/1471-230X-12-165. BMC Gastroenterol. 2012. PMID: 23170950 Free PMC article.
-
[A Meta-analysis on tea drinking and the risk of lung cancer in Chinese population].Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):857-61. Zhonghua Liu Xing Bing Xue Za Zhi. 2012. PMID: 22967345 Chinese.
-
Green tea consumption and risk of breast cancer: A systematic review and updated meta-analysis of case-control studies.Medicine (Baltimore). 2019 Jul;98(27):e16147. doi: 10.1097/MD.0000000000016147. Medicine (Baltimore). 2019. PMID: 31277115 Free PMC article.
-
Association between tea consumption and prevention of coronary artery disease: A systematic review and dose-response meta-analysis.Front Nutr. 2022 Nov 24;9:1021405. doi: 10.3389/fnut.2022.1021405. eCollection 2022. Front Nutr. 2022. PMID: 36505265 Free PMC article.
Cited by
-
Green tea (Camellia sinensis) for the prevention of cancer.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3. Cochrane Database Syst Rev. 2020. PMID: 32118296 Free PMC article.
-
Health Effects of Soy Isoflavones and Green Tea Catechins on Cancer and Cardiovascular Diseases Based on Urinary Biomarker Levels.Molecules. 2022 Dec 14;27(24):8899. doi: 10.3390/molecules27248899. Molecules. 2022. PMID: 36558031 Free PMC article. Review.
-
Preventive and therapeutic effects of green tea on lung cancer: a narrative review of evidence from clinical and basic research.J Thorac Dis. 2022 Dec;14(12):5029-5038. doi: 10.21037/jtd-22-1791. J Thorac Dis. 2022. PMID: 36647481 Free PMC article. Review.
-
Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence.Eur J Clin Nutr. 2021 Jun;75(6):865-876. doi: 10.1038/s41430-020-00710-7. Epub 2020 Aug 20. Eur J Clin Nutr. 2021. PMID: 32820240 Free PMC article. Review.
-
In vitro biological evaluation of epigallocatechin gallate (EGCG) release from three-dimensional printed (3DP) calcium phosphate bone scaffolds.J Mater Chem B. 2023 Jun 21;11(24):5503-5513. doi: 10.1039/d2tb02210a. J Mater Chem B. 2023. PMID: 36637404 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, et al. (2011). Global cancer statistics. CA Cancer J Clin, 61(2):69–90. - PubMed
-
- Le Marchand L, Murphy SP, Hankin JH, et al. (2000). Intake off lavonoidsand lung cancer. J Natl Cancer Inst, 92(2):154–60. - PubMed
-
- Nakachi K, Matsuyama S, Miyake S, et al. (2000). Preventive effects of drinking green tea on cancer and cardiovascular disease:epidemiological evidence for multiple targeting prevention. Biofactors, 13(1–4):49–54. - PubMed
-
- Kuriyama S, Shimazu T, Ohmori K, et al. (2006). Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan:the Ohsaki study. JAMA, 296(10):1255–65. - PubMed
-
- Tang N, Wu Y, Zhou B, et al. (2009). Green tea, black tea consumption and risk of lung cancer:a meta-analysis. Lung Cancer, 65(3):274–83. - PubMed
Publication types
LinkOut - more resources
Full Text Sources